Yan‐Ling Wu

4.5k total citations · 1 hit paper
154 papers, 3.6k citations indexed

About

Yan‐Ling Wu is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Yan‐Ling Wu has authored 154 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 53 papers in Epidemiology and 37 papers in Hepatology. Recurrent topics in Yan‐Ling Wu's work include Liver Disease Diagnosis and Treatment (43 papers), Liver physiology and pathology (32 papers) and Drug-Induced Hepatotoxicity and Protection (18 papers). Yan‐Ling Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (43 papers), Liver physiology and pathology (32 papers) and Drug-Induced Hepatotoxicity and Protection (18 papers). Yan‐Ling Wu collaborates with scholars based in China, Sweden and United States. Yan‐Ling Wu's co-authors include Ji‐Xing Nan, Li‐Hua Lian, Ting Bai, Ying Wan, Quan Jin, Youli Yao, Ben‐Wen Cui, Xin Han, Yong Yang and Peng Sun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Diabetes.

In The Last Decade

Yan‐Ling Wu

149 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Photo-driven cycling electro-Fenton catalysis via the synergistic effect of dual cathodes for energy-efficient water decontamination: Insights into performance, reaction mechanism and toxicity

2025 26 citations Qi Wang, Xin Ma et al. Chemical Engineering Journal profile →

Peers

Countries citing papers authored by Yan‐Ling Wu

Since Specialization

Citations

This map shows the geographic impact of Yan‐Ling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐Ling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐Ling Wu more than expected).

Fields of papers citing papers by Yan‐Ling Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐Ling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐Ling Wu. The network helps show where Yan‐Ling Wu may publish in the future.

Co-authorship network of co-authors of Yan‐Ling Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐Ling Wu. A scholar is included among the top collaborators of Yan‐Ling Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐Ling Wu. Yan‐Ling Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thiazole isomers as potential ALK5 inhibitors alleviate P2X7R-mediated inflammation during liver fibrosis 2025 ·International Immunopharmacology ·Xueli Jiang, (unknown), (unknown), (unknown), Yan‐Ling Wu, Ji‐Xing Nan, Cheng Hua Jin, Li‐Hua Lian	2
2	Bacterial Pneumonia Alters the Respiratory Microbiota and Inflammatory Profile Via the Lung Microbiome-Immune Axis 2025 ·Current Microbiology ·(unknown), (unknown), Zhiming Cai, (unknown), Yan‐Ling Wu	0
3	TLR3-mediated NET formation and macrophage activation in acute liver failure: Targeting IL-36 signaling to attenuate inflammatory drivers 2025 ·International Immunopharmacology ·Zhihong Zhang, Hongxu Yang, (unknown), Xueli Jiang, Siqi Wang, Yan‐Ling Wu, (unknown), Ji‐Xing Nan, Li‐Hua Lian	0
4	Bismuth oxyhalides (BiOX (X = Cl, Br, I)) based composites for photocatalytic antibacterial: Modification strategies, antibacterial mechanisms and prospects 2025 ·Journal of environmental chemical engineering ·(unknown), Xiaoqing Wang, (unknown), Chunjuan Li, Yang Ding, (unknown), (unknown), Huayue Zhu, Qi Wang, Yan‐Ling Wu, (unknown), Guoxiang Yang	9
5	NETs contribute to psoriasiform skin inflammation: A novel therapeutic approach targeting IL-36 cytokines by a small molecule tetrahydroxystilbene glucoside 2024 ·Phytomedicine ·(unknown), Min Jiang, Zhihong Zhang, (unknown), Xiangyuan Wang, Yan‐Ling Wu, Ji‐Xing Nan, Li‐Hua Lian	4
6	Astilbin alleviates hepatic fibrosis through PXR-PINK1/Parkin pathway: A new strategy by regulating hepatic stellate cells-macrophage crosstalk 2024 ·Phytomedicine ·(unknown), (unknown), (unknown), Jia Guo, (unknown), Li‐Hua Lian, Zhenyu Cui, Ji‐Xing Nan, Yan‐Ling Wu	8
7	Sustainable dual-cathode photoelectro-Fenton system enabling oxidative and reductive removal of pollutants via visible light driving Fe sites conversion 2024 ·Chemical Engineering Journal ·Aoxiang Liu, Xin Ma, Boxiong Shen, Hao Du, (unknown), Yan‐Ling Wu, (unknown), Jun Li, Huayue Zhu, Qi Wang	54
8	Synergistic mechanisms for efficient and safe antibiotic removal: Effective adsorption and photocatalytic degradation using aerogels 2024 ·Separation and Purification Technology ·Hao Deng, Yan‐Ling Wu, (unknown), (unknown), Peng Wang, (unknown), Jun Li, Derek Hao, Huayue Zhu, Qi Wang, Qiang Li	60
9	Casting NETs on Psoriasis: The modulation of inflammatory feedback targeting IL-36/IL-36R axis 2024 ·International Immunopharmacology ·Zhihong Zhang, (unknown), Min Jiang, Xiangyuan Wang, (unknown), Yan‐Ling Wu, Ji‐Xing Nan, Li‐Hua Lian	5
10	A therapeutic strategy of parthenolide in improving imiquimod-induced psoriasis-like skin inflammation targeting IL-36/NETs through skin transdermal therapeutic system 2024 ·International Immunopharmacology ·(unknown), Zhihong Zhang, (unknown), Yan‐Ling Wu, Ji‐Xing Nan, Li‐Hua Lian	5
11	Raspberry Ketone Attenuates Hepatic Fibrogenesis and Inflammation via Regulating the Crosstalk of FXR and PGC-1α Signaling 2024 ·Journal of Agricultural and Food Chemistry ·(unknown), (unknown), (unknown), Chong Gao, (unknown), Li‐Hua Lian, Zhenyu Cui, Ji‐Xing Nan, Yan‐Ling Wu	6
12	Isaria cicadae Miquel, as an edible fungus, against dextran sulfate sodium -induced ulcerative colitis in BALB/c mice 2024 ·Journal of Future Foods ·(unknown), Xingyang Li, (unknown), Ruilian Yu, Hao Wu, Qin Wang, Lihui Xu, (unknown), Yan‐Ling Wu	1
13	Dual S-scheme heterojunction via MOF-on-MOF strategy for efficient photoelectrocatalytic removal of organic contaminants: Detoxification and mechanism 2024 ·Journal of Environmental Sciences ·Qiang Li, Qi Zhou, Yan‐Ling Wu, (unknown), (unknown), Hao Deng, Si-Wei Chen, Xuanyang Li, Erpeng Wang, Huayue Zhu, Qi Wang	56
14	An increase in the cytosolic concentration of free calcium ions activates the neutrophil NADPH-oxidase provided that the free fatty acid receptor 2 has been allosterically modulated 2023 ·Cellular Signalling ·(unknown), Yan‐Ling Wu, Martina Sundqvist, Huamei Forsman, Cláes Dahlgren	3
15	Targeting RXFP1 by Ligustilide: A novel therapeutic approach for alcoholic hepatic steatosis 2023 ·International Immunopharmacology ·Hongxu Yang, Xueli Jiang, (unknown), Yan‐Ling Wu, Ji‐Xing Nan, Li‐Hua Lian	6
16	Synthesis of and anti-fibrotic effect of pyrazole derivative J-1048: Inhibition of ALK5 as a novel approach to liver fibrosis targeting inflammation 2023 ·Bioorganic Chemistry ·Hongxu Yang, Fang-Yan Guo, (unknown), Yan‐Ling Wu, Ji‐Xing Nan, Cheng Hua Jin, Li‐Hua Lian	12
17	Factors Associated With Smoking Intentions Among Chinese College Students 2018 ·American Journal of Men s Health ·Yan‐Ling Wu, Hong Fan, (unknown), (unknown)	11
18	Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells 2013 ·International Immunopharmacology ·Ting Bai, Li‐Hua Lian, Yan‐Ling Wu, Ying Wan, Ji‐Xing Nan	102
19	Hepatoprotective effects of salidroside on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice 2009 ·Journal of Pharmacy and Pharmacology ·Yan‐Ling Wu, Li‐Hua Lian, Ying‐Zi Jiang, Ji‐Xing Nan	47
20	[Regulatory T cell based transplant tolerance--freedom from immunosuppression]. 2007 ·PubMed ·T Koshiba, Atsushi Ito, Ying Li, Yan‐Ling Wu, (unknown), Shimon Sakaguchi	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact